Profiling the Dynamic of Binge Eating Disorder (PRODY-BED)

Sponsor
Aarhus University Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05726721
Collaborator
Aalborg University Hospital (Other), Kompetencecenter for Spiseforstyrrelser (Other)
180
38

Study Details

Study Description

Brief Summary

The goal of this observational study is to explore if different and specific profiles can be identified in adults with binge eating disorder (BED) depending on their additional eating pathology, emotion regulation and executive functions. The main questions it aims to answer are:

  • Is there different and specific subgroups of patients with BED according to baseline profiles in emotion regulation, executive function and additional eating pathology (including restriction, chaotic eating, grazing and eating on external cues)?

  • Are subgroups of individuals with BED (based on identified profiles) associated with outcome at end of treatment and follow-up?

  • What is the trajectories in remission rates of specific symptom dimensions (eating disorder pathology, emotion regulation, executive function, and depressive symptoms) in individuals with BED and is there specific trajectory profiles in these dimensions?

  • Is early changes in specific symptom dimensions (eating pathology, emotion regulation, executive function, or depression) associated with outcome of BED? Participants will be asked to fill in questionnaires before treatment as usual, 10 weeks into treatment, at end of treatment and at 6- and 12-month follow-up.

Condition or Disease Intervention/Treatment Phase
  • Other: Treatment as usual, Psychotherapy

Detailed Description

Binge eating disorder (BED) is a severe eating disorder characterized by recurrent episodes of binge eating, where control over eating is lost and huge amounts of food are eaten within a short period of time. Hence, weight issues are often inevitable and overweight is common, as are social, mental as well as physical problems.

The etiology of binge eating disorder is an interplay of neurobiological and environmental factors. Overall pathological eating, including grazing, external, emotional or restrictive eating, is associated with binge eating, and so is dysregulation in the reward center, impairment of executive functions and emotion regulation. The investigators suggest that it is possible to identify specific profiles driving binge eating, depending on the severity of these dimensions, and that these profiles might predict the outcome of treatment. The investigators also suggest that early change in general eating pattern, emotion regulation, and depressive symptoms is associated with binge eating outcome. These assumptions will be tested in a sample of adults in treatment for BED at one of three sites using questionnaires before, during and after treatment, incl. 6- and 12-month follow-ups.

Study Design

Study Type:
Observational
Anticipated Enrollment :
180 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Profiling the Dynamic of Binge Eating Disorder (BED): A Longitudinal Study Examining the Influence of Emotion Regulation, Executive Function, Eating Pattern on BED and Outcome (PRODY-BED)
Anticipated Study Start Date :
Apr 1, 2023
Anticipated Primary Completion Date :
Apr 30, 2025
Anticipated Study Completion Date :
May 31, 2026

Outcome Measures

Primary Outcome Measures

  1. Subgroups of BED-profiles [Baseline data]

    Subgroups of BED-profiles depending on degree and type of additional eating pathology measured by DEBQ (Dutch Eating Behaviour Questionnaire), emotion regulation problems measured by DERS-16 (Difficulties in Emotion Regulation Scale), and executive problems mesured by BRIEF-A .

  2. Binge eating episodes EoT [At end of therapy up to 30 weeks]

    Number of binge eating episodes

  3. Binge eating episodes FU6m [At 6-month follow-up]

    Number of binge eating episodes

  4. Binge eating episodes FU12m [At 12-month follow-up]

    Number of binge eating episodes

Secondary Outcome Measures

  1. Eating disorder pathology [At end of treatment up to 30 weeks]

    Overall self-reported eating disorder pathology measured by the total score of Eating Disoder Examination Questionnaire (EDE-Q), minimum score 0, maximum score 6, higher scores indicating eating pathology

  2. Eating disorder pathology [At 6-month follow-up]

    Overall self-reported eating disorder pathology measured by the total score of EDE-Q, minimum score 0, maximum score 6, higher scores indicating eating pathology

  3. Eating disorder pathology [At 12-month follow-up]

    Overall self-reported eating disorder pathology measured by the total score of EDE-Q, minimum score 0, maximum score 6, higher scores indicating eating pathology

  4. Functional impairment [At end of treatment up to 30 weeks]

    Self-reported functional impairment measured by the total score of WSAS, minimum score 0, maximum score 8, higher scores indicating more impairment

  5. Functional impairment [At 6-month follow-up]

    Self-reported functional impairment measured by the total score of WSAS, minimum score 0, maximum score 8, higher scores indicating more impairment

  6. Functional impairment [At 12-month follow-up]

    Self-reported functional impairment measured by the total scorer of WSAS, minimum score 0, maximum score 8, higher scores indicating more impairment

  7. Well-being [At end of treatment up to 30 weeks]

    Self-reported well-being measured by the total score of WHO-5, minimum score 0, maximum score 25, with lower scores indicating worst imaginable well-bing

  8. Well-being [At 6-month follow-up]

    Self-reported well-being measured by the total score of WHO-5, minimum score 0, maximum score 25, with lower scores indicating worst imaginable well-bing

  9. Well-being [At 12-month follow-up]

    Self-reported well-being measured by the total score of WHO-5, minimum score 0, maximum score 25, with lower scores indicating worst imaginable well-bing

  10. Trajectories of binge eating [From baseline to 12-month follow-up]

    Trajectories of frequency of binge eating across time measured by self-reported binge eating in Eating Disorder Examination questionnaire (EDE-Q)

  11. Trajectories of restrictive eating [From baseline to 12-month follow-up]

    Trajectories of restrictive eating across time measured by the DEBQ restraint eating scale, minum score 1, maximum score 5, higher scores indicating more restricted eating

  12. Trajectories of emotional eating [From baseline to 12-month follow-up]

    Trajectories of emotional eating across time measued by the DEBQ emotional eating scale, minimum score 1, maximum score 5, higher scores indicating more emotional eating

  13. Trajectories of eating on external cues [From baseline to 12-month follow-up]

    Trajectories of eating on external cues across time measured by the DEBQ external eating scale, minimum score 1, maximum score 5, higher scores indicating more eating on external cues

  14. Trajectories of grazing [From baseline to 12-month follow-up]

    Trajectories of grazing across time measured by the total score of the Grazing Questionnaire, minimum 0, maximum 28, higher scores indcating greater grazing behavior

  15. Trajectories of emotional regulation [From baseline to 12-month follow-up]

    Trajectories of emotional regulation across time measured by the total score of DERS-16, minimum score 16, maximum score 80, higher socres indicating greater diffuculties

  16. Trajectories of executive function [From baseline to 12-month follow-up]

    Trajectories of executive function across time measured by the BRIEF-A (Behavior rating inventory of Executive Function Adult version) Global Executive Composite T-Scores, minimum score 0, maximum score 90, higher scores indicating executive problems

  17. Trajectories of depression [From baseline to 12-month follow-up]

    Trajectories of depression across time measured by Beck Depression Inventory 2, minimum score 0, maximum score 63, higher scores indicating more depressive symptoms

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Age 18+,

  • diagnosed with Binge eating Disorder,

  • and offered treatment at on of the inclusion sites.

Exclusion Criteria:
  • Severe psychiatric comorbidity (e.g. psychosis, severe developmental disorder, severe cogntive impairement)

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Aarhus University Hospital
  • Aalborg University Hospital
  • Kompetencecenter for Spiseforstyrrelser

Investigators

  • Principal Investigator: Loa Clausen, PhD, Aarhus University Hospital, Psychiatry

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Loa Clausen, Senior Researcher, Aarhus University Hospital
ClinicalTrials.gov Identifier:
NCT05726721
Other Study ID Numbers:
  • PRODY-BED
First Posted:
Feb 14, 2023
Last Update Posted:
Feb 14, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Loa Clausen, Senior Researcher, Aarhus University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 14, 2023